Tags: job | cuts | Dendreon | Provenge

Dendreon to Cut 15 Percent of Workforce as Provenge Disappoints

Tuesday, 12 Nov 2013 11:08 AM

Dendreon Corp. plans to cut 150 jobs, or about 15 percent of its workforce, to trim operating expenses after sales of its prostate-cancer drug Provenge missed analysts’ estimates.

Dendreon will take a $7.5 million charge related to severance this quarter and next, the Seattle-based company said in a regulatory filing. The reductions will help save about $125 million in operating expenses, with cost of goods sold being reduced by about $30 million.

The drugmaker is cutting costs as sales of Provenge, approved in 2010, fail to meet expectations. The drug, Dendreon’s only marketed product, generated third-quarter revenue of $68 million, the company reported, missing the $75 million average estimate of analysts. That’s a 13 percent decline from a year earlier. Dendreon said in early August that the medicine’s revenue wouldn’t increase this year as forecast.

“This marks the third consecutive top-line miss for the company in 2013, so we think few investors were expecting much of a turnaround story at this point,” Chris Raymond, an analyst with Robert W. Baird, wrote in a research note. “While the workforce reduction was probably well anticipated, savings from past restructuring efforts took longer to realize than anticipated.”

Dendreon rose 7.4 percent to $2.69 at 9:56 a.m. New York time. The shares had fallen 53 percent this year through yesterday.

Dendreon said in July 2012 that it would cut more than 600 jobs and reduce costs by $150 million as it sought to reach profitability.

In October, Bloomberg News reported Dendreon is working with JPMorgan Chase & Co. to find a buyer. The company declined to comment at the time.

© Copyright 2017 Bloomberg News. All rights reserved.

 
1Like our page
2Share
Companies
Dendreon Corp. plans to cut 150 jobs, or about 15 percent of its workforce, to trim operating expenses after sales of its prostate-cancer drug Provenge missed analysts' estimates.
job,cuts,Dendreon,Provenge
266
2013-08-12
Tuesday, 12 Nov 2013 11:08 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved